You are here: Home » News-CM » Companies » Results
Business Standard

Jenburkt Pharmaceuticals standalone net profit rises 97.04% in the September 2017 quarter

Capital Market 

Sales rise 28.09% to Rs 36.75 crore

Net profit of Jenburkt Pharmaceuticals rose 97.04% to Rs 9.97 crore in the quarter ended September 2017 as against Rs 5.06 crore during the previous quarter ended September 2016. Sales rose 28.09% to Rs 36.75 crore in the quarter ended September 2017 as against Rs 28.69 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales36.7528.69 28 OPM %33.7424.15 -PBDT13.257.45 78 PBT12.877.00 84 NP9.975.06 97

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, December 06 2017. 16:16 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU